Insider Buying: agilon health, inc. (NYSE:AGL) Director Purchases $28,500.00 in Stock

agilon health, inc. (NYSE:AGL) Director Diana Mckenzie bought 12,500 shares of the stock in a transaction that occurred on Monday, November 25th. The stock was purchased at an average price of $2.28 per share, for a total transaction of $28,500.00. Following the completion of the purchase, the director now directly owns 51,319 shares in the company, valued at $117,007.32. The trade was a 32.20 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.

Diana Mckenzie also recently made the following trade(s):

• On Monday, December 9th, Diana Mckenzie purchased 7,500 shares of agilon health stock. The shares were purchased at an average price of $2.20 per share, with a total value of $16,500.00.

agilon health Stock Performance

NYSE:AGL opened at $2.25 on Friday. The firm has a market capitalization of $927.04 million, a PE ratio of -2.39 and a beta of 0.51. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06. agilon health, inc. has a 12-month low of $1.50 and a 12-month high of $13.76. The firm has a 50-day moving average price of $2.44 and a 200 day moving average price of $4.40.

agilon health (NYSE:AGL) last issued its earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.19). The company had revenue of $1.45 billion during the quarter, compared to analyst estimates of $1.47 billion. agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. During the same period in the previous year, the company posted ($0.06) earnings per share. Research analysts anticipate that agilon health, inc. will post -0.52 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities analysts recently weighed in on the company. Evercore ISI cut their price objective on agilon health from $7.00 to $4.00 and set an “in-line” rating for the company in a research report on Tuesday, October 8th. Bank of America lowered agilon health from a “buy” rating to an “underperform” rating and set a $3.00 price target for the company. in a report on Wednesday, October 2nd. Citigroup reduced their price objective on agilon health from $2.50 to $1.75 and set a “sell” rating for the company in a research report on Wednesday, November 13th. William Blair lowered shares of agilon health from an “outperform” rating to a “market perform” rating in a research report on Friday, November 8th. Finally, TD Cowen reduced their price target on shares of agilon health from $6.00 to $2.00 and set a “hold” rating for the company in a report on Monday, November 11th. Three equities research analysts have rated the stock with a sell rating, fifteen have given a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $4.38.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. State Street Corp increased its position in shares of agilon health by 3.0% during the 3rd quarter. State Street Corp now owns 7,449,706 shares of the company’s stock worth $29,277,000 after purchasing an additional 215,733 shares in the last quarter. Geode Capital Management LLC grew its stake in agilon health by 1.2% during the third quarter. Geode Capital Management LLC now owns 6,893,517 shares of the company’s stock worth $27,097,000 after buying an additional 84,889 shares during the last quarter. Citigroup Inc. increased its holdings in shares of agilon health by 2,251.5% during the third quarter. Citigroup Inc. now owns 2,028,246 shares of the company’s stock worth $7,971,000 after buying an additional 1,941,993 shares in the last quarter. AQR Capital Management LLC raised its stake in shares of agilon health by 3,338.5% in the second quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company’s stock valued at $8,871,000 after acquiring an additional 1,316,990 shares during the last quarter. Finally, Barclays PLC boosted its holdings in shares of agilon health by 21.2% in the 3rd quarter. Barclays PLC now owns 1,228,952 shares of the company’s stock worth $4,830,000 after acquiring an additional 214,830 shares in the last quarter.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.